2 studies found for:    11001068 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy
Conditions: Pancreas Cancer;   Ovarian Cancer;   Melanoma;   Sarcoma
Intervention: Drug: Regorafenib
2 Withdrawn Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer
Condition: Cervical Cancer
Interventions: Drug: Bevacizumab;   Drug: Carboplatin;   Radiation: Radiation Therapy

Indicates status has not been verified in more than two years